BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34651117)

  • 1. Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience.
    Rinehardt H; Kassem M; Morgan E; Palettas M; Stephens JA; Suresh A; Ganju A; Lustberg M; Wesolowski R; Sardesai S; Stover D; Vandeusen J; Cherian M; Prieto Eibl MDPG; Miah A; Alnahhas I; Giglio P; Puduvalli VK; Ramaswamy B; Williams N; Noonan AM
    Eur J Breast Health; 2021 Oct; 17(4):371-377. PubMed ID: 34651117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer.
    Ko Y; Gwak HS; Park EY; Joo J; Lee YJ; Lee SH; Kwon JW; Shin SH; Yoo H
    J Neurooncol; 2019 Jul; 143(3):553-562. PubMed ID: 31089925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis.
    Kim HS; Park JB; Gwak HS; Kwon JW; Shin SH; Yoo H
    World J Surg Oncol; 2019 Mar; 17(1):59. PubMed ID: 30917830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment pattern and outcomes of leptomeningeal carcinomatosis in India - a retrospective study.
    Goyal G; Singh A; Avaronnan M; Raut NV; Talreja V; Chandrasekharan A; Gupta K; Bhosale B; Kothari RK; Parekh D; Poladia BP; Ghosh J; Talele A; Shrirangwar S; Karpe A
    Lancet Reg Health Southeast Asia; 2024 May; 24():100331. PubMed ID: 38756165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors.
    Ozdemir Y; Yildirim BA; Topkan E
    J Neurooncol; 2016 Sep; 129(2):329-35. PubMed ID: 27306442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor.
    Kwon BS; Cho YH; Yoon SK; Lee DH; Kim SW; Kwon DH; Lee JC; Choi CM
    Thorac Cancer; 2020 Feb; 11(2):436-442. PubMed ID: 31910497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors for leptomeningeal carcinomatosis in breast cancer patients with parenchymal brain metastases.
    Jung JM; Kim S; Joo J; Shin KH; Gwak HS; Lee SH
    J Korean Neurosurg Soc; 2012 Sep; 52(3):193-9. PubMed ID: 23115660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian Adenocarcinoma With Leptomeningeal Metastases.
    Bayas A; Kondramashin A; Waheeds S; Swerdloff MA
    Cureus; 2022 Aug; 14(8):e27577. PubMed ID: 36059325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis.
    Hyun JW; Park JH; Kang BG; Park EY; Park B; Joo J; Kim JK; Kim SH; Jeong JH; Lee HW; Park KD; Choi KG; Hwang SH; Gwak HS; Kim HJ
    Oncotarget; 2017 Aug; 8(32):53326-53335. PubMed ID: 28881814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged Survival and Restored Useful Life by Early Induction of Intrathecal Chemotherapy in a Patient with Leptomeningeal Carcinomatosis from Ovarian Cancer.
    Takahara K; Katayama M; Tamura R
    Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective Analysis of Cerebrospinal Fluid Profiles in 228 Patients with Leptomeningeal Carcinomatosis : Differences According to the Sampling Site, Symptoms, and Systemic Factors.
    Shim Y; Gwak HS; Kim S; Joo J; Shin SH; Yoo H
    J Korean Neurosurg Soc; 2016 Nov; 59(6):570-576. PubMed ID: 27847569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptomeningeal carcinomatosis from gastric cancer: single institute retrospective analysis of 9 cases.
    Kim NH; Kim JH; Chin HM; Jun KH
    Ann Surg Treat Res; 2014 Jan; 86(1):16-21. PubMed ID: 24761402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal carcinomatosis originating from advanced gastric cancer--a report of three cases and review of the literatures.
    Kusumoto T; Kimura Y; Sugiyama M; Ohta M; Tsutsumi N; Sakaguchi Y; Ikejiri K; Oki E; Saeki H; Morita M; Ikeda T; Furuta T; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Nov; 104(11):456-63. PubMed ID: 24620642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis.
    Yoo BC; Lee JH; Kim KH; Lin W; Kim JH; Park JB; Park HJ; Shin SH; Yoo H; Kwon JW; Gwak HS
    Oncotarget; 2017 Nov; 8(60):101203-101214. PubMed ID: 29254157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer.
    Kosmas C; Malamos NA; Tsavaris NB; Stamataki M; Stefanou S; Gregoriou A; Rokana S; Vartholomeou M; Antonopoulos MJ
    J Neurooncol; 2002 Feb; 56(3):265-73. PubMed ID: 12061734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated leptomeningeal carcinomatosis (carcinomatous meningitis) after taxane-induced major remission in patients with advanced breast cancer.
    Kosmas C; Malamos NA; Tsavaris NB; Stamataki M; Gregoriou A; Rokana S; Vartholomeou M; Antonopoulos MJ
    Oncology; 2002; 63(1):6-15. PubMed ID: 12187065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Analysis of the Clinical Outcomes of Leptomeningeal Metastasis in Patients with Solid Tumors.
    Kim H; Lee EM
    Brain Tumor Res Treat; 2018 Oct; 6(2):54-59. PubMed ID: 30381917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptomeningeal carcinomatosis as primary manifestation of pancreatic cancer.
    Trinh VT; Medina-Flores R; Chohan MO
    J Clin Neurosci; 2016 Aug; 30():124-127. PubMed ID: 26972704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions.
    Lee DW; Lee KH; Kim JW; Keam B
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid diversion and outcomes for lung cancer patients with leptomeningeal carcinomatosis.
    Su YH; Chiang CL; Yang HC; Hu YS; Chen YW; Luo YH; Chen CJ; Wu HM; Lin CJ; Lee CC
    Acta Neurochir (Wien); 2022 Feb; 164(2):459-467. PubMed ID: 33646444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.